Mastodon

United States Trade Representative (USTR)

Some Surprises in the European Commission’s New Intellectual Property Strategy

The European Commission’s new intellectual property (IP) strategy is out and it holds a number of surprises for access to medicines. After restating the importance of IP for innovation and for fostering a competitive European industry, the Commission lays out a number…